9月10日，库珀医疗盘后下跌6.29%，报59.05美元/股，成交额512.87万美元。
消息面上，公司于盘后披露中期财报，归母净利润为5290万美元，同比大幅下滑72.45%；稀释每股收益仅0.27美元，远低于此前一季度的0.67美元，第二财季盈利明显恶化。与此同时，董事会表示一系列临时性因素影响了库珀外科业务的估值认知，称该影响并非源于基本面或长期战略的实质性变化。此前高盛已将公司目标价下调至63美元并维持卖出评级，当前股价已跌破该目标位。公司同时宣布新增两名独立董事以优化治理结构。
库珀医疗是一家全球性医疗器械公司，通过CooperVision和CooperSurgical两大业务部门运营，主营隐形眼镜及生育与妇女健康产品。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.